Frequently Asked Questions

Why did you establish a diagnostics company specializing in substance use disorders?

Despite the vast resources invested in addiction treatment, drug-involved overdose deaths in the U.S. have steadily increased in recent years. So, we set out to focus on the unique needs of people with a SUD – and the providers who treat them – to improve patient outcomes based on the reality that specialized, data-informed care is often more effective than generalized care.

What are the benefits of a specialized toxicology panel?

Toxicology that is tailored to substance use disorders gives a provider only the information they need to understand a patient’s progress in treatment. A specialized toxicology panel eliminates unnecessary information, while highlighting information providers need most to help a patient achieve recovery.

What are SUDx’s digital tools?

The SUDx dashboard includes digital tools providers can use to optimize treatment for patients with a substance use disorder (SUD). Enabled by clinically validated, patent-pending algorithms, these tools include a patient’s stability scores, which quantify the likelihood of substance use and medication adherence at a patient’s next appointment, and a Treatment Twin which projects the most likely treatment path in response to standard interventions.

These digital tools, along with a patient’s historical toxicology data, are captured graphically and numerically on SUDx’s clinical dashboard, which providers can access with a tablet, phone, or computer. 

How did you develop your stability scoring models?

SUDx’s Data Scientist Albert Burgess-Hull, PhD collaborated with scientists at the National Institute of Drug Abuse (NIDA) and addiction psychiatrists at a leading academic teaching hospital to develop real-time computational risk models for an OUD patient population. As documented in the peer-reviewed Journal of Addiction Medicine, the stability score models enable us to present historical patient stability scores graphically.

What is the SUDx Treatment Twin?

The SUDx Treatment Twin illustrates the most likely path a patient will take in treatment. The Treatment Twin display allows providers to visualize how each patient will progress if normal standards of care are deployed.  Greater than 80% of patients respond well to treatment but the balance of patients in the remaining two trajectories will likely prove resistant to standard interventions.

What are the benefits of the Treatment Twin?

Results generated from SUDx’s Treatment Twin model can inspire confidence in recovery for most patients while implying additional interventions for those who are expected to be resistant to standard treatment. It allows clinicians to personalize care for each patient, better plan and allocate resources to the right patients at the right time, and tailor interventions with greater foresight and efficiency.

How dependable are the digital tools in predicting an OUD patient’s response to standard interventions?

The digital tools, which reflect more than 100,000 patient samples to date, are continuously re-validated as new data are collected.

Can the digital tools be used to better understand a population of patients or just individuals?

Yes. In addition to helping to improve health outcomes on a visit-by-visit, patient-by-patient basis, metrics displayed on SUDx’s dashboard and generated by our proprietary models can be used to provide an overall description of the health status of a selected group of patients, clinics, or practices. These data can also be combined with other objective metrics to assess the overall quality of outcomes, including treatment retention. Talk to us if you are interested in seeing the data aggregated for your practice.

Why did you create the clinical dashboard?

SUDx created the clinical dashboard to put the best, most relevant patient information at a provider’s fingertips to enhance the efficiency and efficacy of their care. By using a tablet, phone, or computer, a provider can access the dashboard’s graphical display of a patient’s historic toxicology results, eliminating the time consuming process of referencing multiple PDF files. Providers treating patients with an OUD will also see a patient’s stability scores and Treatment Twin.

What steps do you take to protect a patient’s confidentiality?

The confidentiality with which a patient’s urine toxicology and health data are collected and maintained is assured by robust standards including end-to-end encryption, strong authentication controls, network security, security testing and audits, and regular training. The patient data used to develop, validate, and refine our models are stored on Google’s cloud servers with commercial-grade security frameworks.

How do I have samples collected, get results and order supplies?

SUDx is at its core, a traditional toxicology lab. Patient samples are generally collected by providers and transported via SUDx courier to our laboratory. Results can be delivered via encrypted email, fax, or directly to customer EHRs. Supplies can be ordered on our website.

What customer service does SUDx provide?

SUDx strives to provide the best customer service in the industry, ensuring that your needs are met with the highest level of attention and care. Reach out anytime with questions, concerns, or suggestions.

Is SUDx licensed and accredited?

SUDx is accredited by COLA, licensed by the State of Maryland and Certified by CLIA –  standards developed to ensure the accuracy, reliability and timeliness of test results.

Compounds SUDx Tests For:

TEST
Units
Cutoff
Alcohol ETS
ETS
ng/mL
<200
Amphetamine
Amphetamine
ng/mL
<100
Methamphetamine
ng/mL
<100
Methamphetamine
ng/mL
<100
Phentermine
ng/mL
<100
MDA
ng/mL
<100
MDMA
ng/mL
<100
Benzodiazepines
Alpha-Hydroxyalprazolam
ng/mL
<50
Diazepam
ng/mL
<50
Lorazepam
ng/mL
<100
Nordiazepam
ng/mL
<50
Oxazepam
ng/mL
<50
Temazepam
ng/mL
<50
7-Aminoclonazepam
ng/mL
<50
Buprenorphine
Norbuprenorphine
ng/mL
<10
Buprenorphine
ng/mL
<10
Benzoylecgonine
Cocaine metabolite (Benzoyleconine)
ng/mL
<50
Fentanyl
Norfentanyl
ng/mL
<5
Fentanyl
ng/mL
<2
Acetyl fentanyl
ng/mL
<2
Acetyl norfentanyl
ng/mL
<5
Gabapentin
Gabapentin
ng/mL
<500
Heroin
6-Acetylmorphine
ng/mL
<10
Morphine
ng/mL
<50
Kratom
7-Hydroxymitragynine
ng/mL
<10
Methadone
Methadone
ng/mL
<20
EDDP
ng/mL
<50
Opioid Analogs
Naltrexone
ng/mL
<50
Naloxone
ng/mL
<25
Opiates
Codeine
ng/mL
<50
Dihydrocodeine
ng/mL
<50
Hydrocodone
ng/mL
<50
Hydromorphone
ng/mL
<50
Norhydrocodone
ng/mL
<25
Semi-synthetic Opioids
Noroxycodone
ng/mL
<50
Oxycodone
ng/mL
<50
Oxymorphone
ng/mL
<50
Tianeptine
Tianeptine
ng/mL
<10
Xylazine
Xylazine
ng/mL
<10
Specimen Validity Testing
Urine Creatinine
mg/mL
>19.9
Cannabinoids
THC
ng/mL
<50
Additional Individual Compounds
Carisoprodol(SOMA)
ng/mL
<50
Ketamine
ng/mL
<100
Phencyclidine(PCP)
ng/mL
<50
Pregabalin
ng/mL
<5
Psilocybin
ng/mL
<100
Quetiapine
ng/mL
<100
Tapentadol
ng/mL
<50
Tramadol
ng/mL
<50
Zolpidem
ng/mL
<50